RBC call yesterday Donnatal
Interesting response to Donnatal sales growth question. Would have liked to see their body language but what seemed like laughter at the perceived 'lowball' projection of only 25-50% growth in this one drug alone tells me a whole lot about where mgmt believes they can take this company. Not to mention all that is going on with AMCO. Based on short position o/s and about 20 trading days to March.23 I wouldn't be surprised with a 20% run up pre-earnings of course contingent on general market sentiment. $72 by summer !!! GLTA.